Children who have had major urological procedures benefited postoperatively from locally infused anesthetics delivered using the ON-Q pain relief system, researchers from the Children’s Hospital of Orange County say.
Cancer sufferers are more likely to die from their condition if their kidneys are not functioning properly, a new study published online in the American Journal of Kidney Diseases claims.
Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that the US Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia (IDA) in pre-dialysis patients with chronic kidney disease (CKD).
A new UCSF-led study of nearly 3,000 individuals links obesity to the development of kidney disease. The work also shows that, when properly measured, declines in kidney function are detectable long before the emergence of other obesity-related diseases such as diabetes and high blood pressure.
Young-onset type 2 diabetes mellitus (T2DM) is associated with greater mortality, increased complications, and unfavorable cardiovascular risk versus type 1 diabetes mellitus (T1DM) with a similar age of onset, according to a study published in Diabetes Care (2013;36:3863-3869).
A recent study indicates that patients with acute kidney injury (AKI) later experience more major cardiac and renal problems than do patients who suffer a myocardial infarction (MI).